Cargolux, based in Luxembourg, is Europe’s leading all-cargo airline with a modern and efficient fleet composed of a total of thirty Boeing 747F. With over 2,250 employees around the world, the company has more than 85 offices in over 50 countries and covers a global network of destinations. We took the opportunity and invited Stavros Evangelakakis, Head of Global Healthcare at Cargolux, to talk to us about the most recent developments in airfreight, challenges during the COVID-19 pandemic and the strict processes required to maintain the cold chain of pharmaceutical products.
“In 2020, Cargolux witnessed a double-digit increase in pharmaceutical transports.”
Stavros Evengelakakis sums up Cargolux' pharmaceutical business in 2020.
“As international flights became scarce, our airline provided an air bridge between Europe, Asia, and the Americas.”
Cargolux' Head of Global Health remembers the beginnings of the first lockdowns in Europe.
“The transport of the COVID-19 vaccine itself is regular business for Cargolux. The real challenges lie in the logistics around the flight such as appropriate storage at the correct temperature.”
On the challenges that have to be taken into account during pharmaceutical transports.
“We also streamlined our operation and optimized our network throughout the year to adapt to the global flow of goods.”
Stavros Evangelakakis recalls the company's reaction to the global outbreak.